BDNF and its high-affinity tyrosine kinase receptor, tropomyosin receptor kinase B (TrkB), have been demonstrated to be overexpressed in multiple cancers, such as neuroblastoma, oral, breast, lung, and colorectal cancer. Here, BDNF is linked to cancer.